Healthcare -
Biotechnology - NASDAQ - US
$ 10.99
3.1 %
$ 669 M
Market Cap
-3.28
P/E
PLRX - CAPITAL EXPENDITURES
Capital Expenditures PLRX - Pliant Therapeutics, Inc.
-921 K
LAST VALUE
31.33%
2 YEAR CAGR
16.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR